These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19929659)

  • 1. Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.
    Mensah A; Vignal-Clermont C; Mehanna C; Morel X; Galatoire O; Jacomet PV; Morax S
    Orbit; 2009; 28(6):354-62. PubMed ID: 19929659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients.
    Vermot-Desroches V; Thia-Soui-Tchong K; Raymond P; Filip A; Orgiazzi J; Jouanneau E; Froment Tilikete C; Borson-Chazot F; Manet R; Abeillon Du Payrat J
    Ann Endocrinol (Paris); 2023 Aug; 84(4):430-439. PubMed ID: 37086950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.
    Liao SL; Chang TC; Lin LL
    Am J Ophthalmol; 2006 May; 141(5):810-818. PubMed ID: 16527228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysthyroid Optic Neuropathy.
    Saeed P; Tavakoli Rad S; Bisschop PHLT
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S60-S67. PubMed ID: 29927882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy.
    Currò N; Covelli D; Vannucchi G; Campi I; Pirola G; Simonetta S; Dazzi D; Guastella C; Pignataro L; Beck-Peccoz P; Ratiglia R; Salvi M
    Thyroid; 2014 May; 24(5):897-905. PubMed ID: 24417307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy.
    Lipski A; Eckstein A; Esser J; Loesch C; Mann K; Mohr C; Jurklies B
    Br J Ophthalmol; 2011 Feb; 95(2):222-6. PubMed ID: 20584712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in 53 patients with cat scratch optic neuropathy.
    Chi SL; Stinnett S; Eggenberger E; Foroozan R; Golnik K; Lee MS; Bhatti MT
    Ophthalmology; 2012 Jan; 119(1):183-7. PubMed ID: 21959368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab as first treatment option in optic neuropathy secondary to Graves' orbitopathy.
    Pascual-Camps I; Molina-Pallete R; Bort-Martí MA; Todolí J; España-Gregori E
    Orbit; 2018 Dec; 37(6):450-453. PubMed ID: 29420104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern visual evoked potentials in the early diagnosis of optic neuropathy in the course of Graves' ophthalmopathy.
    Pawłowski P; Myśliwiec J; Mrugacz M; Bakunowicz-Łazarczyk A; Górska M
    Endokrynol Pol; 2006; 57(2):122-6. PubMed ID: 16773586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves orbitopathy.
    Onaran Z; Konuk O; Oktar SÖ; Yücel C; Unal M
    Curr Eye Res; 2014 Jul; 39(7):666-72. PubMed ID: 24502333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy.
    Tsaloumas MD; Good PA; Burdon MA; Misson GP
    Eye (Lond); 1994; 8 ( Pt 6)():638-45. PubMed ID: 7867819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
    Kemchoknatee P; Tangon D; Srisombut T
    BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysthyroid optic neuropathy: evaluation and management.
    Dolman PJ
    J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.